id | C00001735 |
---|---|
Name | Harmaline |
CAS RN | 304-21-2 |
Standard InChI | InChI=1S/C13H14N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-4,7,15H,5-6H2,1-2H3 |
Standard InChI (Main Layer) | InChI=1S/C13H14N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-4,7,15H,5-6H2,1-2H3 |
Phytochemical cluster | No. 4 |
---|---|
KCF-S cluster | No. 7732 |
By standard InChI | CHEMBL340807 |
---|---|
By standard InChI Main Layer | CHEMBL340807 |
By LinkDB | C06536 |
---|
By CAS RN | D006246 |
---|
class name | count |
---|---|
rosids | 3 |
family name | count |
---|---|
Malpighiaceae | 1 |
Passifloraceae | 1 |
Nitrariaceae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Banisteria caapi | 4268 | Malpighiaceae | rosids | Viridiplantae |
Passiflora incarnata | 159425 | Passifloraceae | rosids | Viridiplantae |
Peganum harmala | 43879 | Nitrariaceae | rosids | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL340807 |
CHEMBL1614110
(1)
|
1 / 0 |
Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 | Ste7 | CHEMBL340807 |
CHEMBL1062820
(1)
|
1 / 1 |
Q9P1W9 | Serine/threonine-protein kinase pim-2 | Pim | CHEMBL340807 |
CHEMBL1061086
(1)
|
0 / 0 |
Q8TDX7 | Serine/threonine-protein kinase Nek7 | Nek | CHEMBL340807 |
CHEMBL1060151
(1)
|
0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL340807 |
CHEMBL2114784
(1)
|
1 / 1 |
Q15759 | Mitogen-activated protein kinase 11 | p38 | CHEMBL340807 |
CHEMBL1052111
(1)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL340807 |
CHEMBL1063767
(1)
|
0 / 0 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL340807 |
CHEMBL1614079
(1)
|
0 / 0 |
O15530 | 3-phosphoinositide-dependent protein kinase 1 | Pdk1 | CHEMBL340807 |
CHEMBL1063811
(1)
|
0 / 0 |
P41240 | Tyrosine-protein kinase CSK | Csk | CHEMBL340807 |
CHEMBL1061954
(1)
|
0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | CHEMBL340807 |
CHEMBL1614103
(1)
CHEMBL1614031
(1)
|
1 / 1 |
P45984 | Mitogen-activated protein kinase 9 | Jnk | CHEMBL340807 |
CHEMBL1060122
(1)
|
0 / 0 |
P29466 | Caspase-1 | C14 | CHEMBL340807 |
CHEMBL1614158
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL340807 |
CHEMBL1062776
(1)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL340807 |
CHEMBL1061959
(1)
|
0 / 0 |
O14757 | Serine/threonine-protein kinase Chk1 | Chk1 | CHEMBL340807 |
CHEMBL1051374
(1)
|
0 / 0 |
Q13315 | Serine-protein kinase ATM | Atypical serine/threonine protein kinase PIKK subfamily | CHEMBL340807 |
CHEMBL1614153
(1)
|
1 / 4 |
Q8IWQ3 | Serine/threonine-protein kinase BRSK2 | CAMK serine/threonine protein kinase BRSK subfamily | CHEMBL340807 |
CHEMBL1051367
(1)
|
0 / 0 |
P27448 | MAP/microtubule affinity-regulating kinase 3 | CAMK serine/threonine protein kinase MARK subfamily | CHEMBL340807 |
CHEMBL1063734
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL340807 |
CHEMBL1614544
(1)
|
11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL340807 |
CHEMBL1614281
(1)
CHEMBL1614361
(1)
|
3 / 2 |
Q05513 | Protein kinase C zeta type | Iota | CHEMBL340807 |
CHEMBL1052114
(1)
|
0 / 0 |
P47898 | 5-hydroxytryptamine receptor 5A | Serotonin receptor | CHEMBL340807 |
CHEMBL618086
(1)
|
0 / 0 |
P11309 | Serine/threonine-protein kinase pim-1 | Pim | CHEMBL340807 |
CHEMBL1063736
(1)
|
0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | CHEMBL340807 |
CHEMBL666137
(1)
CHEMBL1056886
(1)
|
0 / 0 |
P23443 | Ribosomal protein S6 kinase beta-1 | p70 | CHEMBL340807 |
CHEMBL1052119
(1)
|
0 / 0 |
Q00535 | Cyclin-dependent kinase 5 | Cdk5 | CHEMBL340807 |
CHEMBL666138
(1)
|
0 / 0 |
Q9UQB9 | Aurora kinase C | Aur | CHEMBL340807 |
CHEMBL1062797
(1)
|
1 / 1 |
Q9HBH9 | MAP kinase-interacting serine/threonine-protein kinase 2 | CAMK serine/threonine protein kinase MNK subfamily | CHEMBL340807 |
CHEMBL1060126
(1)
|
0 / 0 |
Q9NQU5 | Serine/threonine-protein kinase PAK 6 | STE serine/threonine protein kinase PAKB subfamily | CHEMBL340807 |
CHEMBL1063719
(1)
|
0 / 0 |
Q16644 | MAP kinase-activated protein kinase 3 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL340807 |
CHEMBL1061148
(1)
|
0 / 0 |
Q9H422 | Homeodomain-interacting protein kinase 3 | CMGC dual-specificity kinase HIPK | CHEMBL340807 |
CHEMBL1061964
(1)
|
0 / 0 |
Q14680 | Maternal embryonic leucine zipper kinase | Melk | CHEMBL340807 |
CHEMBL1052104
(1)
|
0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | CHEMBL340807 |
CHEMBL1614067
(1)
|
1 / 2 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL340807 |
CHEMBL1614166
(1)
|
1 / 0 |
Q15746 | Myosin light chain kinase, smooth muscle | Mlck | CHEMBL340807 |
CHEMBL1062028
(1)
|
1 / 1 |
Q13188 | Serine/threonine-protein kinase 3 | STE serine/threonine protein kinase MST subfamily | CHEMBL340807 |
CHEMBL1060209
(1)
|
0 / 0 |
P31751 | RAC-beta serine/threonine-protein kinase | Akt | CHEMBL340807 |
CHEMBL1061917
(1)
|
2 / 2 |
O75582 | Ribosomal protein S6 kinase alpha-5 | CAMK serine/threonine protein kinase MSKB subfamily | CHEMBL340807 |
CHEMBL1062767
(1)
|
0 / 0 |
O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Other serine/threonine protein kinase | CHEMBL340807 |
CHEMBL1062809
(1)
|
0 / 0 |
Q16513 | Serine/threonine-protein kinase N2 | Pkn | CHEMBL340807 |
CHEMBL1060217
(1)
|
0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | CHEMBL340807 |
CHEMBL1062021
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL340807 |
CHEMBL1614458
(4)
|
0 / 0 |
Q8N5S9 | Calcium/calmodulin-dependent protein kinase kinase 1 | META serine/threonine protein kinase subfamily | CHEMBL340807 |
CHEMBL1061198
(1)
|
0 / 0 |
Q9P286 | Serine/threonine-protein kinase PAK 7 | STE serine/threonine protein kinase PAKB subfamily | CHEMBL340807 |
CHEMBL1061163
(1)
|
0 / 0 |
Q96SB4 | SRSF protein kinase 1 | Srpk | CHEMBL340807 |
CHEMBL1060225
(1)
|
0 / 0 |
Q92630 | Dual specificity tyrosine-phosphorylation-regulated kinase 2 | CMGC dual-specificity kinase DYRK2 | CHEMBL340807 |
CHEMBL1062802
(1)
|
0 / 0 |
O43781 | Dual specificity tyrosine-phosphorylation-regulated kinase 3 | CMGC dual-specificity kinase DYRK2 | CHEMBL340807 |
CHEMBL1061956
(1)
|
0 / 0 |
O96013 | Serine/threonine-protein kinase PAK 4 | STE serine/threonine protein kinase PAKB subfamily | CHEMBL340807 |
CHEMBL1061162
(1)
|
0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL340807 |
CHEMBL1738606
(1)
|
0 / 0 |
P42858 | Huntingtin | Unclassified protein | CHEMBL340807 |
CHEMBL1613918
(1)
|
1 / 1 |
O75496 | Geminin | Unclassified protein | CHEMBL340807 |
CHEMBL2114780
(1)
|
0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | CHEMBL340807 |
CHEMBL1060118
(1)
|
0 / 0 |
Q15418 | Ribosomal protein S6 kinase alpha-1 | Rskb | CHEMBL340807 |
CHEMBL1052116
(1)
|
0 / 0 |
O15264 | Mitogen-activated protein kinase 13 | p38 | CHEMBL340807 |
CHEMBL1060132
(1)
|
0 / 0 |
P53779 | Mitogen-activated protein kinase 10 | Jnk | CHEMBL340807 |
CHEMBL1060123
(1)
|
0 / 1 |
P51955 | Serine/threonine-protein kinase Nek2 | Nek | CHEMBL340807 |
CHEMBL1062822
(1)
|
0 / 0 |
Q96RR4 | Calcium/calmodulin-dependent protein kinase kinase 2 | META serine/threonine protein kinase subfamily | CHEMBL340807 |
CHEMBL1052080
(1)
|
0 / 0 |
Q9BUB5 | MAP kinase-interacting serine/threonine-protein kinase 1 | CAMK serine/threonine protein kinase MNK subfamily | CHEMBL340807 |
CHEMBL1063759
(1)
|
0 / 0 |
P48730 | Casein kinase I isoform delta | Ck1 | CHEMBL340807 |
CHEMBL1062001
(1)
|
1 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | CHEMBL340807 |
CHEMBL1614217
(1)
|
1 / 1 |
Q96GD4 | Aurora kinase B | Aur | CHEMBL340807 |
CHEMBL1051365
(1)
|
0 / 0 |
P49137 | MAP kinase-activated protein kinase 2 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL340807 |
CHEMBL1051342
(1)
|
0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL340807 |
CHEMBL1052091
(1)
|
0 / 0 |
P45983 | Mitogen-activated protein kinase 8 | Jnk | CHEMBL340807 |
CHEMBL1061969
(1)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL340807 |
CHEMBL1613910
(2)
CHEMBL1614227
(1)
|
3 / 3 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL340807 |
CHEMBL1614038
(3)
|
2 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL340807 |
CHEMBL1738588
(1)
|
0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL340807 |
CHEMBL2020014
(1)
CHEMBL2020015
(1)
|
1 / 0 |
P53350 | Serine/threonine-protein kinase PLK1 | PLK serine/threonine protein kinase subfamily | CHEMBL340807 |
CHEMBL1052115
(1)
|
0 / 0 |
Q8IW41 | MAP kinase-activated protein kinase 5 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL340807 |
CHEMBL1061101
(1)
|
0 / 0 |
O75116 | Rho-associated protein kinase 2 | Rock | CHEMBL340807 |
CHEMBL1063671
(1)
|
0 / 0 |
P55210 | Caspase-7 | C14 | CHEMBL340807 |
CHEMBL1613779
(2)
|
0 / 0 |
P31749 | RAC-alpha serine/threonine-protein kinase | Akt | CHEMBL340807 |
CHEMBL1061172
(1)
|
4 / 1 |
O00141 | Serine/threonine-protein kinase Sgk1 | AGC serine/threonine protein kinase SGK subfamily | CHEMBL340807 |
CHEMBL1063673
(1)
|
0 / 0 |
P51812 | Ribosomal protein S6 kinase alpha-3 | Rskb | CHEMBL340807 |
CHEMBL1063683
(1)
|
2 / 2 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL340807 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
|
0 / 1 |
Q9HC98 | Serine/threonine-protein kinase Nek6 | Nek | CHEMBL340807 |
CHEMBL1060128
(1)
|
0 / 0 |
Q9H2X6 | Homeodomain-interacting protein kinase 2 | CMGC dual-specificity kinase HIPK | CHEMBL340807 |
CHEMBL1062015
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL340807 |
CHEMBL1614211
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL340807 |
CHEMBL1614421
(3)
CHEMBL1614502
(1)
|
4 / 3 |
O96017 | Serine/threonine-protein kinase Chk2 | Rad53 | CHEMBL340807 |
CHEMBL1062000
(1)
|
4 / 1 |
Q14012 | Calcium/calmodulin-dependent protein kinase type 1 | Camk1 | CHEMBL340807 |
CHEMBL1051272
(1)
|
0 / 0 |
P17612 | cAMP-dependent protein kinase catalytic subunit alpha | Pka | CHEMBL340807 |
CHEMBL1062854
(1)
|
0 / 0 |
Q13627 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | CMGC dual-specificity kinase DYRK1 | CHEMBL340807 |
CHEMBL1062005
(1)
|
1 / 0 |
P53778 | Mitogen-activated protein kinase 12 | p38 | CHEMBL340807 |
CHEMBL1062773
(1)
|
0 / 0 |
O00418 | Eukaryotic elongation factor 2 kinase | Atypical serine/threonine protein kinase alpha subfamily | CHEMBL340807 |
CHEMBL1060113
(1)
|
0 / 0 |
Q8TD08 | Mitogen-activated protein kinase 15 | Mapk | CHEMBL340807 |
CHEMBL1062012
(1)
|
0 / 0 |
Q86V86 | Serine/threonine-protein kinase pim-3 | Pim | CHEMBL340807 |
CHEMBL1061912
(1)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL340807 |
CHEMBL1794536
(1)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL340807 |
CHEMBL1613914
(3)
|
0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | CHEMBL340807 |
CHEMBL1613829
(2)
CHEMBL1794433
(1)
|
0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL340807 |
CHEMBL1738442
(1)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL340807 |
CHEMBL1614364
(1)
|
1 / 1 |
O00255 | Menin | Unclassified protein | CHEMBL340807 |
CHEMBL1614531
(2)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL340807 |
CHEMBL1614531
(2)
|
1 / 3 |
P20248 | Cyclin-A2 | Other cytosolic protein | CHEMBL340807 |
CHEMBL1056886
(1)
|
0 / 0 |
P78396 | Cyclin-A1 | Other cytosolic protein | CHEMBL340807 |
CHEMBL1056886
(1)
|
0 / 0 |
P68400 | Casein kinase II subunit alpha | Ck2 | CHEMBL340807 |
CHEMBL1061205
(1)
|
0 / 0 |
P19784 | Casein kinase II subunit alpha' | Ck2 | CHEMBL340807 |
CHEMBL1061205
(1)
|
0 / 0 |
P67870 | Casein kinase II subunit beta | REG serine/threonine protein kinase family | CHEMBL340807 |
CHEMBL1061205
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D006246 | 6347 |
CCL2
GDCF-2 HC11 HSMCR30 MCAF MCP-1 MCP1 SCYA2 SMC-CF |
chemokine (C-C motif) ligand 2 | Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of CCL2 protein] |
decreases reaction
/ increases expression |
protein |
12107048
|
D006246 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[Cycloheximide co-treated with Harmaline] results in decreased expression of CYP1A1 protein] |
affects cotreatment
/ decreases expression / decreases reaction |
protein |
22037238
|
D006246 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | [Cycloheximide co-treated with Harmaline] results in decreased expression of CYP1A1 protein |
affects cotreatment
/ decreases expression |
protein |
22037238
|
D006246 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Harmaline inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein] |
decreases reaction
/ increases activity |
protein |
22037238
|
D006246 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Harmaline inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of and results in increased activity of CYP1A1 protein] |
decreases reaction
/ increases activity / increases expression |
protein |
22037238
|
D006246 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Harmaline inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
22037238
|
D006246 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Harmaline results in decreased activity of CYP1A1 protein |
decreases activity
|
protein |
22037238
|
D006246 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Harmaline results in decreased stability of CYP1A1 protein |
decreases stability
|
protein |
22037238
|
D006246 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Harmaline inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]] |
affects binding
/ decreases reaction / increases activity |
protein |
12065299
|
D006246 | 3553 |
IL1B
IL-1 IL1-BETA IL1F2 |
interleukin 1, beta | Harmaline inhibits the reaction [IL1B protein results in increased secretion of IL8 protein] |
decreases reaction
/ increases secretion |
protein |
12065299
|
D006246 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Harmaline inhibits the reaction [IL1B protein results in increased secretion of IL8 protein] |
decreases reaction
/ increases secretion |
protein |
12065299
|
D006246 | 3576 |
IL8
CXCL8 GCP-1 GCP1 LECT LUCT LYNAP MDNCF MONAP NAF NAP-1 NAP1 |
interleukin 8 | Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL8 protein] |
decreases reaction
/ increases expression |
protein |
12107048
|
D006246 | 4790 |
NFKB1
EBP-1 KBF1 NF-kB1 NF-kappa-B NF-kappaB NFKB-p105 NFKB-p50 NFkappaB p105 p50 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Harmaline inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]] |
affects binding
/ decreases reaction / increases activity |
protein |
12065299
|
D006246 | 4790 |
NFKB1
EBP-1 KBF1 NF-kB1 NF-kappa-B NF-kappaB NFKB-p105 NFKB-p50 NFkappaB p105 p50 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of NFKB1 protein] |
affects localization
/ decreases reaction / increases activity |
protein |
12107048
|
D006246 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Harmaline inhibits the reaction [IL1B protein results in increased activity of [RELA protein binds to NFKB1 protein]] |
affects binding
/ decreases reaction / increases activity |
protein |
12065299
|
D006246 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | Harmaline inhibits the reaction [lipopolysaccharide, E coli O55-B5 affects the localization of and results in increased activity of RELA protein] |
affects localization
/ decreases reaction / increases activity |
protein |
12107048
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#615224 | Advanced sleep phase syndrome, familial, 2; fasps2 |
P48730
|
#613780 | Aortic aneurysm, familial thoracic 7; aat7 |
Q15746
|
#208900 | Ataxia-telangiectasia; at |
Q13315
|
#210900 | Bloom syndrome; blm |
P54132
|
#114480 | Breast cancer |
O96017
P31749 |
#615279 | Cardiofaciocutaneous syndrome 3; cfc3 |
Q02750
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#303600 | Coffin-lowry syndrome; cls |
P51812
|
#114500 | Colorectal cancer; crc |
P31749
|
#615109 | Cowden syndrome 6; cws6 |
P31749
|
#125853 | Diabetes mellitus, noninsulin-dependent; niddm |
P31751
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#240900 | Hypoinsulinemic hypoglycemia with hemihypertrophy; hihghh |
P31751
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#609265 | Li-fraumeni syndrome 2; lfs2 |
O96017
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#614104 | Mental retardation, autosomal dominant 7; mrd7 |
Q13627
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300844 | Mental retardation, x-linked 19; mrx19 |
P51812
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#259500 | Osteogenic sarcoma |
O96017
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#176807 | Prostate cancer |
O96017
|
#176920 | Proteus syndrome |
P31749
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#243060 | Spermatogenic failure 5; spgf5 |
Q9UQB9
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00881 | Li-Fraumeni syndrome |
O96017
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P31751 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
H00027 | Ovarian cancer |
P31751
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P51812
(related)
Q99714 (related) |
H00574 | Coffin-Lowry syndrome (CLS) |
P51812
(related)
|
H00606 | Early infantile epileptic encephalopathy |
P53779
(related)
|
H00094 | DNA repair defects |
P54132
(related)
Q13315 (related) |
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00523 | Noonan syndrome and related disorders |
Q02750
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
Q13315
(related)
|
H00064 | Ataxia telangiectasia (AT) |
Q13315
(related)
|
H00848 | Ataxia with ocular apraxia (AOA) |
Q13315
(related)
|
H00801 | Familial thoracic aortic aneurysm and dissection (TAAD) |
Q15746
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H01282 | Spermatogenic failure |
Q9UQB9
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D056486 | D006246 | Drug-Induced Liver Injury |
marker/mechanism
|
20833158
|
|
D020329 | D006246 | Essential Tremor |
marker/mechanism
|
19497322
|
|
D006212 | D006246 | Hallucinations |
marker/mechanism
|
20833158
|
|
D014202 | D006246 | Tremor |
marker/mechanism
|
181685
986992 12044659 15894058 17587636 |